1
Kuppen, Malou C.P., Westgeest, Hans M., van den Eertwegh, Alfons J.M., van Moorselaar, Reindert J.A., van Oort, Inge M., Tascilar, Metin, Mehra, Niven, Lavalaye, Jules, Somford, Diederik M., Aben, Katja K.H., Bergman, Andre M., de Wit, Ronald, van den Bergh, A. C. M. (Fons), de Groot, Carin A.Uyl, Gerritsen, Winald R.
Veröffentlicht in: Kuppen , M C P , Westgeest , H M , van den Eertwegh , A J M , van Moorselaar , R J A , van Oort , I M , Tascilar , M , Mehra , N , Lavalaye , J , Somford , D M , Aben , K K H , Bergman , A M , de Wit , R , van den Bergh , A C M , de Groot , C A U & Gerritsen , W R 2022 , ' Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population : Results From the CAPRI-Study in the Netherlands ' , Clinical genitourinary cancer , vol. 20 , no. 1 , pp. 43-52 . https://doi.org/10.1016/j.clgc.2021.10.008;
2022
Veröffentlicht in: Kuppen , M C P , Westgeest , H M , van den Eertwegh , A J M , van Moorselaar , R J A , van Oort , I M , Tascilar , M , Mehra , N , Lavalaye , J , Somford , D M , Aben , K K H , Bergman , A M , de Wit , R , van den Bergh , A C M , de Groot , C A U & Gerritsen , W R 2022 , ' Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population : Results From the CAPRI-Study in the Netherlands ' , Clinical genitourinary cancer , vol. 20 , no. 1 , pp. 43-52 . https://doi.org/10.1016/j.clgc.2021.10.008;
2022
2
Westgeest, Hans M., Kuppen, Malou C. P., van den Eertwegh, Alphonsus J. M., de Wit, Ronald, Coenen, Juleon L. L. M., van den Berg, H. P. (Pieter), Mehra, Niven, van Oort, Inge M., Fossion, Laurent M. C. L., Hendriks, Mathijs P., Bloemendal, Haiko J., van de Luijtgaarden, Addy C. M., Huinink, Daan ten Bokkel, van den Bergh, A. C. M. (Fons), van den Bosch, Joan, Polee, Marco B., Weijl, Nir, Bergman, Andre M., Uyl-de Groot, Carin A., Gerritsen, Winald R.
Veröffentlicht in: Westgeest , H M , Kuppen , M C P , van den Eertwegh , A J M , de Wit , R , Coenen , J L L M , van den Berg , H P , Mehra , N , van Oort , I M , Fossion , L M C L , Hendriks , M P , Bloemendal , H J , van de Luijtgaarden , A C M , Huinink , D T B , van den Bergh , A C M , van den Bosch , J , Polee , M B , Weijl , N , Bergman , A M , Uyl-de Groot , C A & Gerritsen , W R 2019 , ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI : Observational Study in the Netherlands ' , Clinical genitourinary cancer , vol. 17 , no. 5 , pp. E946-E956 . https://doi.org/10.1016/j.clgc.2019.05.018;
2019
Veröffentlicht in: Westgeest , H M , Kuppen , M C P , van den Eertwegh , A J M , de Wit , R , Coenen , J L L M , van den Berg , H P , Mehra , N , van Oort , I M , Fossion , L M C L , Hendriks , M P , Bloemendal , H J , van de Luijtgaarden , A C M , Huinink , D T B , van den Bergh , A C M , van den Bosch , J , Polee , M B , Weijl , N , Bergman , A M , Uyl-de Groot , C A & Gerritsen , W R 2019 , ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI : Observational Study in the Netherlands ' , Clinical genitourinary cancer , vol. 17 , no. 5 , pp. E946-E956 . https://doi.org/10.1016/j.clgc.2019.05.018;
2019